These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 3612003)

  • 41. [Epidemiological findings on gastric and duodenal ulcer in the pre- and post-cimetidine era. Study of 2,119 cases].
    Garau G; Faret S; Balconi V; Cannas GP; Boero A
    Minerva Dietol Gastroenterol; 1987; 33(3):209-16. PubMed ID: 3670670
    [No Abstract]   [Full Text] [Related]  

  • 42. [Use of statizol in the treatment of patients with peptic ulcer of the stomach and duodenum].
    Panchenkov RT; Semenov VV; Popov IuP; Demidov DA; Bogdanov IuV
    Khirurgiia (Mosk); 1984 Sep; (9):111-4. PubMed ID: 6513366
    [No Abstract]   [Full Text] [Related]  

  • 43. Controlled trial comparing colloidal bismuth subcitrate tablets, cimetidine and placebo in the treatment of gastric ulceration.
    Tytgat GN; van Bentem N; van Olffen G; Dekker W; Rutgeerts L; de Boer J
    Scand J Gastroenterol Suppl; 1982; 80():31-8. PubMed ID: 6761850
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB).
    Lacey LF; Frazer NM; Keene ON; Smith JT
    Eur J Clin Pharmacol; 1994; 47(2):177-80. PubMed ID: 7859806
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protective drugs in the treatment of gastroduodenal ulcer disease.
    Koelz HR
    Scand J Gastroenterol Suppl; 1986; 125():156-64. PubMed ID: 3547612
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of peptic ulcer with ranitidine and cimetidine in a single nocturnal dose].
    Klinger J; Maggiolo P; Arteaga H; Goić A
    Rev Med Chil; 1987 Jul; 115(7):645-7. PubMed ID: 3331025
    [No Abstract]   [Full Text] [Related]  

  • 47. [Various problems of the treatment of gastric and duodenal ulcers].
    Murashko VV; Balalykin AS; Shylle ChI; Maliarova LP; Lapshina SV
    Klin Med (Mosk); 1987 Jan; 65(1):122-7. PubMed ID: 3560822
    [No Abstract]   [Full Text] [Related]  

  • 48. A comparison of ranitidine and cimetidine in the treatment of gastric ulcer. A two-centre study.
    De Jong MJ; Pop P; Schenk Y; Stuifbergen WN; Lockefeer JH
    Neth J Med; 1982; 25(9):308-11. PubMed ID: 6294536
    [No Abstract]   [Full Text] [Related]  

  • 49. [Effect of bismuth salts in elimination of Helicobacter pylori from gastric mucosa in patients with duodenal ulcer].
    Romańczyk T; Nowakowska-Duława E; Nowakowska M; Rogala-Zawada D; Kłuciński P
    Med Dosw Mikrobiol; 1993; 45(2):209-12. PubMed ID: 8309299
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relapse rates following initial ulcer healing with sucralfate and cimetidine.
    Marks IN; Wright JP; Lucke W; Girdwood AH
    Scand J Gastroenterol Suppl; 1983; 83():53-6. PubMed ID: 6579632
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Ulfamid in the combined therapy of gastric and duodenal peptic ulcer].
    Pal'tsev AI; Maslennikova TA
    Ter Arkh; 1997; 69(2):62-3. PubMed ID: 9173582
    [No Abstract]   [Full Text] [Related]  

  • 52. [Results of a controlled comparative study between cimetidine and pirenzepin in 60 patients with ulcera ventriculi or duodeni].
    Mittelstaedt A; Zilly A; Verhoeven A; Mielenz H
    Fortschr Med; 1981 Nov; 99(42):1764-8. PubMed ID: 7030892
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Colloidal bismuth subcitrate.
    Simjee AE
    S Afr Med J; 1988 Jul; 74 Suppl():61-3. PubMed ID: 3291158
    [No Abstract]   [Full Text] [Related]  

  • 55. Ulcer healing and relapse rates after initial treatment with cimetidine or sucralfate.
    Marks IN; Lucke W; Wright JP; Girdwood AH
    J Clin Gastroenterol; 1981; 3(Suppl 2):163-5. PubMed ID: 7033353
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN; Nio CY
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():152-61. PubMed ID: 3660894
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Gastrin level during cimetidine in patients with peptic ulcer].
    Schmeisser W; Malchow H; Schenzle D; Egberts EH; Sewing KF; Dölle W
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():427-9. PubMed ID: 611997
    [No Abstract]   [Full Text] [Related]  

  • 58. [Comparative evaluation of the efficacy of complex anti-ulcer therapy and monotherapy].
    Grigor'ev PIa; Khar'kovskiĭ NN; Elina NA; Iakovenko EP
    Sov Med; 1984; (2):100-1. PubMed ID: 6719194
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of peptic ulcer with ulcosilvanil].
    Grigor'ev PIa; Khar'kovskiĭ NN; Iakovenko EP; Elina NA; Kashirina LV
    Sov Med; 1984; (2):102-4. PubMed ID: 6719195
    [No Abstract]   [Full Text] [Related]  

  • 60. [Multicenter controlled clinical trial in the treatment of peptic ulcer with cimetidine].
    Zespołowa P
    Pol Tyg Lek; 1980 Jan; 35(2):61-4. PubMed ID: 6988816
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.